HALOZYME THERAPEUTICS INC shareholders Q3 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Walleye Capital LLC 3,400$129,8800.00%
MILLENNIUM MANAGEMENT LLC 7,400$282,6800.00%
CWM, LLC 1,967$750.00%
Clearstead Advisors, LLC 156$5,9600.00%
Amundi 14,600$533,6300.00%
Walleye Capital LLC 4,800$183,3600.00%
FARMERS & MERCHANTS INVESTMENTS INC 57$2,1770.00%
WOLVERINE TRADING, LLC 8,300$317,0600.00%
WOLVERINE TRADING, LLC 5,691$217,3960.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 11,863$453,1680.00%
CENTRAL TRUST Co 354$13,5230.00%
FMR LLC 126,818$4,844,4560.00%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 15$5730.00%
Walleye Trading LLC 3,000$114,6000.00%
Twin Tree Management, LP 1,550$59,2100.00%
Glassman Wealth Services 68$2,5980.00%
SJS Investment Consulting Inc. 21$8030.00%
AdvisorNet Financial, Inc 19$7260.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 150$5,7300.00%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.